13.13
price up icon0.00%   0.00
after-market 시간 외 거래: 13.13
loading
전일 마감가:
$13.13
열려 있는:
$12.93
하루 거래량:
927.21K
Relative Volume:
0.98
시가총액:
$1.08B
수익:
$288.00K
순이익/손실:
$-228.06M
주가수익비율:
-3.0894
EPS:
-4.25
순현금흐름:
$-168.82M
1주 성능:
-1.28%
1개월 성능:
-13.96%
6개월 성능:
-46.56%
1년 성능:
-10.07%
1일 변동 폭
Value
$12.87
$13.72
1주일 범위
Value
$12.18
$14.22
52주 변동 폭
Value
$9.90
$27.20

Viridian Therapeutics Inc Stock (VRDN) Company Profile

Name
명칭
Viridian Therapeutics Inc
Name
전화
617.272.4600
Name
주소
221 CRESCENT STREET, WALTHAM
Name
직원
143
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
VRDN's Discussions on Twitter

VRDN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VRDN
Viridian Therapeutics Inc
13.13 1.08B 288.00K -228.06M -168.82M -4.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-19 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-11-25 개시 TD Cowen Buy
2024-09-11 재확인 Needham Buy
2024-06-11 개시 Wolfe Research Outperform
2024-06-06 개시 Goldman Buy
2024-05-09 다운그레이드 B. Riley Securities Buy → Neutral
2024-05-09 다운그레이드 Ladenburg Thalmann Buy → Neutral
2023-06-14 개시 BTIG Research Buy
2023-06-14 재개 Credit Suisse Outperform
2023-05-30 개시 RBC Capital Mkts Outperform
2023-04-17 개시 Wells Fargo Overweight
2023-03-30 개시 Stifel Buy
2022-12-19 개시 Cowen Outperform
2022-12-19 개시 Needham Buy
2022-12-16 개시 Credit Suisse Outperform
2022-12-01 개시 H.C. Wainwright Buy
2022-06-23 개시 B. Riley Securities Buy
2021-11-18 개시 SVB Leerink Outperform
2021-10-12 개시 Evercore ISI Outperform
2021-01-25 개시 Ladenburg Thalmann Buy
모두보기

Viridian Therapeutics Inc 주식(VRDN)의 최신 뉴스

pulisher
Apr 18, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Geode Capital Management LLC Has $31.81 Million Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Thyroid Eye Disease Market Predicted to See Upsurge Through - openPR.com

Apr 15, 2025
pulisher
Apr 15, 2025

Retinitis Pigmentosa Market Growth to Accelerate in Forecast - openPR.com

Apr 15, 2025
pulisher
Apr 15, 2025

Retinitis Pigmentosa Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics - Barchart.com

Apr 15, 2025
pulisher
Apr 11, 2025

Sector Update: Health Care - TradingView

Apr 11, 2025
pulisher
Apr 11, 2025

Graves Ophthalmopathy Therapeutics Market Size in 7MM - openPR.com

Apr 11, 2025
pulisher
Apr 10, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Position Lifted by Vanguard Group Inc. - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

American Century Companies Inc. Has $2.18 Million Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

KLP Kapitalforvaltning AS Acquires New Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Viridian Therapeutics Appoints Jeff Ajer to its Board of Directors - BioSpace

Apr 07, 2025
pulisher
Apr 07, 2025

Viridian Therapeutics Appoints Jeff Ajer to Board - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

Viridian Therapeutics appoints Jeff Ajer to board - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by Corebridge Financial Inc. - Defense World

Apr 07, 2025
pulisher
Apr 04, 2025

Stifel maintains Buy on Viridian Therapeutics, $41 target By Investing.com - Investing.com Canada

Apr 04, 2025
pulisher
Apr 03, 2025

(VRDN) Trading Report - news.stocktradersdaily.com

Apr 03, 2025
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Boosts Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Financial Analysis: Viridian Therapeutics (NASDAQ:VRDN) versus ACI Global (OTCMKTS:ACGJ) - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Quantbot Technologies LP Invests $164,000 in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Acquired by Swiss National Bank - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Raymond James Financial Inc. Makes New $6.02 Million Investment in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Where are the Opportunities in (VRDN) - news.stocktradersdaily.com

Mar 24, 2025
pulisher
Mar 22, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

AlphaQuest LLC Acquires 1,519 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Commit To Buy Viridian Therapeutics At $12.50, Earn 13.2% Annualized Using Options - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by Bank of New York Mellon Corp - Defense World

Mar 19, 2025
pulisher
Mar 16, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Bought by Arizona State Retirement System - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 15, 2025
pulisher
Mar 15, 2025

410,440 Shares in Viridian Therapeutics, Inc. (NASDAQ:VRDN) Acquired by Victory Capital Management Inc. - Defense World

Mar 15, 2025
pulisher
Mar 12, 2025

Viridian Therapeutics at Leerink’s Conference: Progress in TED Treatments By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 10, 2025

Viridian Therapeutics appoints new director, sees board resignation By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Viridian Therapeutics Announces Inducement Stock Option Grants - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Viridian Therapeutics appoints new director, sees board resignation - Investing.com India

Mar 10, 2025
pulisher
Mar 06, 2025

What is B. Riley’s Forecast for VRDN Q1 Earnings? - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Principal Financial Group Inc. Has $3.42 Million Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

What is B. Riley’s Estimate for VRDN Q2 Earnings? - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Decoding Viridian Therapeutics Inc (VRDN): A Strategic SWOT Insi - GuruFocus.com

Mar 04, 2025
pulisher
Mar 04, 2025

Viridian Therapeutics inks new $300M sales agreement By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Viridian Therapeutics Terminates Prior $175 Million Sale Agreement -March 04, 2025 at 06:36 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Viridian Therapeutics Enters New $300M Sale Agreement - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Viridian Therapeutics inks new $300M sales agreement - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Rhumbline Advisers Has $1.92 Million Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Viridian Therapeutics Faces Uncertainty Amid Regulatory Approval Challenges - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

Viridian Therapeutics, Inc.\DE SEC 10-K Report - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Q1 EPS Estimates for Viridian Therapeutics Raised by Wedbush - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

How to Take Advantage of moves in (VRDN) - Stock Traders Daily

Mar 02, 2025
pulisher
Mar 02, 2025

Viridian Therapeutics: Positive Data In TED, Strong Cash Position, 1.5-Year Window - Seeking Alpha

Mar 02, 2025
pulisher
Mar 02, 2025

FY2027 EPS Forecast for Viridian Therapeutics Cut by Analyst - Defense World

Mar 02, 2025

Viridian Therapeutics Inc (VRDN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):